tiprankstipranks
Advertisement
Advertisement
Harrow price target lowered to $88 from $91 at Cantor Fitzgerald
PremiumThe FlyHarrow price target lowered to $88 from $91 at Cantor Fitzgerald
2M ago
Analyst Reiterates Buy Rating and Maintains $63 Price Target as Temporary Headwinds Mask Strengthening Ophthalmic Growth Outlook
Premium
Ratings
Analyst Reiterates Buy Rating and Maintains $63 Price Target as Temporary Headwinds Mask Strengthening Ophthalmic Growth Outlook
2M ago
Harrow Health Earnings Call Highlights Growth Amid Headwinds
Premium
Company Announcements
Harrow Health Earnings Call Highlights Growth Amid Headwinds
2M ago
3 High P/E Stocks with 50%+ Upside Potential in 2026
PremiumMarket News3 High P/E Stocks with 50%+ Upside Potential in 2026
2M ago
Harrow announces issuance of J-Code for Iopidine 1%
Premium
The Fly
Harrow announces issuance of J-Code for Iopidine 1%
3M ago
Harrow selects LogiCare3PL as distribution partner
Premium
The Fly
Harrow selects LogiCare3PL as distribution partner
3M ago
Harrow Health Expands Senior Notes Offering for Growth
PremiumCompany AnnouncementsHarrow Health Expands Senior Notes Offering for Growth
3M ago
Harrow Health Prices $50 Million Senior Notes Offering
Premium
Company Announcements
Harrow Health Prices $50 Million Senior Notes Offering
3M ago
Opportunistic Capital Strategy and Iheezo Growth Opportunities Support Harrow Health Buy Rating
Premium
Ratings
Opportunistic Capital Strategy and Iheezo Growth Opportunities Support Harrow Health Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100